Evidence map›Paper›PMID 37305426›Full record

ArticleTobacco induced diseases2023

Examining the association of habitual e-cigarette use with inflammation and endothelial dysfunction in young adults: The VAPORS-Endothelial function study.

Ellen Boakye, S M Iftekhar Uddin, Ngozi Osuji, Jill Meinert, Olufunmilayo H Obisesan, Mohammadhassan Mirbolouk, Erfan Tasdighi, Omar El-Shahawy, John Erhabor, Albert D Osei and 6 more

Open access · goldAbstract read
In one paragraph

Article in Tobacco induced diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Ellen BoakyeJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, The Johns Hopkins University, Baltimore, United States.
S M Iftekhar UddinDepartment of Medicine, Brookdale University Hospital Medical Center, New York City, United States.
Ngozi OsujiDepartment of Internal Medicine, University of Pittsburg Medical Center, Pittsburg, United States.
Jill MeinertDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Olufunmilayo H ObisesanDepartment of Medicine, MedStar Union Memorial Hospital, Baltimore, United States.
Mohammadhassan MirboloukJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, The Johns Hopkins University, Baltimore, United States.
Erfan TasdighiJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, The Johns Hopkins University, Baltimore, United States.
Omar El-ShahawyThe American Heart Association Tobacco Regulation and Addiction Center, University of Louisville, Dallas, United States.
John ErhaborJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, The Johns Hopkins University, Baltimore, United States.
Albert D OseiDepartment of Medicine, MedStar Union Memorial Hospital, Baltimore, United States.
Tanuja RajanJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, The Johns Hopkins University, Baltimore, United States.
Michael PatatanianDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Janet T HolbrookDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Aruni BhatnagarThe American Heart Association Tobacco Regulation and Addiction Center, University of Louisville, Dallas, United States.
Shyam S BiswalDepartment of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Michael J BlahaJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, The Johns Hopkins University, Baltimore, United States.
Johns Hopkins University · USAmerican Heart Association · USMedStar Union Memorial Hospital · USBrookdale University Hospital and Medical Center · USPittsburg State University · US

Funding

PATHOPHYSIOLOGY OF MYOCARDIAL DISEASEST32HL007227 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Chulan Kwon, WENDY S POST · 1985 to 2026
$21.2M
University of Louisville Center for Integrative Environmental Health SciencesP30ES030283 · NIEHS · UNIVERSITY OF LOUISVILLE · PI J CHRISTOPHER STATES · 2020 to 2026
$10.0M
NHLBI NIH HHS T32 HL007227NIEHS NIH HHS P30 ES030283
6 · The paper itself

Abstract

introductionAcute exposure to e-cigarette aerosol has been shown to have potentially deleterious effects on the cardiovascular system. However, the cardiovascular effects of habitual e-cigarette use have not been fully elucidated. Therefore, we aimed to assess the association of habitual e-cigarette use with endothelial dysfunction and inflammation - subclinical markers known to be associated with increased cardiovascular risk.

methodsIn this cross-sectional study, we analyzed data from 46 participants (23 exclusive e-cigarette users; 23 non-users) enrolled in the VAPORS-Endothelial function study. E-cigarette users had used e-cigarettes for ≥6 consecutive months. Non-users had used e-cigarettes <5 times and had a negative urine cotinine test (<30 ng/mL). Flow-mediated dilation (FMD) and reactive hyperemia index (RHI) were used to assess endothelial dysfunction, and we assayed high-sensitivity C-reactive protein, interleukin-6, fibrinogen, p-selectin, and myeloperoxidase as serum measures of inflammation. We used multivariable linear regression to assess the association of e-cigarette use with the markers of endothelial dysfunction and inflammation.

resultsOf the 46 participants with mean age of 24.3 ± 4.0 years, the majority were males (78%), non-Hispanic (89%), and White (59%). Among non-users, 6 had cotinine levels <10 ng/mL while 17 had levels 10-30 ng/mL. Conversely, among e-cigarette users, the majority (14 of 23) had cotinine ≥500 ng/mL. At baseline, the systolic blood pressure was higher among e-cigarette users than non-users (p=0.011). The mean FMD was slightly lower among e-cigarette users (6.32%) compared to non-users (6.53%). However, in the adjusted analysis, current e-cigarette users did not differ significantly from non-users in their mean FMD (Coefficient=2.05; 95% CI: -2.52-6.63) or RHI (Coefficient= -0.20; 95% CI: -0.88-0.49). Similarly, the levels of inflammatory markers were generally low and did not differ between e-cigarette users and non-users.

conclusionsOur findings suggest that e-cigarette use may not be significantly associated with endothelial dysfunction and systemic inflammation in relatively young and healthy individuals. Longer term studies with larger sample sizes are needed to validate these findings.

Indexed as

e-cigaretteendothelial dysfunctionflow-mediated dilationinflammationreactive hyperemia index

Identifiers

PMID37305426
PMCPMC10257221
OpenAlexW4380291399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.